Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Novartis
Fuji
Boehringer Ingelheim
AstraZeneca
Queensland Health
Accenture
Harvard Business School
Colorcon

Generated: October 22, 2017

DrugPatentWatch Database Preview

UNIVASC Drug Profile

« Back to Dashboard

Which patents cover Univasc, and what generic Univasc alternatives are available?

Univasc is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in UNIVASC is moexipril hydrochloride. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the moexipril hydrochloride profile page.

Summary for Tradename: UNIVASC

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list43
Clinical Trials: see list2
Patent Applications: see list833
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:UNIVASC at DailyMed

Pharmacology for Tradename: UNIVASC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-001Apr 19, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-002Apr 19, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: UNIVASC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-001Apr 19, 1995► Subscribe► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-002Apr 19, 1995► Subscribe► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-002Apr 19, 1995► Subscribe► Subscribe
Ucb Inc
UNIVASC
moexipril hydrochloride
TABLET;ORAL020312-001Apr 19, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Fuji
Accenture
Julphar
Novartis
US Department of Justice
Johnson and Johnson
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot